Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Treatment of myelodysplastic syndromes with low-dose oral 6-thioguanine.

Treatment of myelodysplastic syndromes with low-dose oral 6-thioguanine. Med Pediatr Oncol. 1988; 16(1):17-20.

View in: PubMed

© 2021 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.